Resultados de la búsqueda 81-90 of 17000 for Botox Benefits

1. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purpose of this study is to evaluate thymoma recurrence rates in patients who underwent thymectomy. 3D Ultrasound Imaging for Breast Cancer ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

4. Bone Marrow Transplant

   Thank you for your interest in becoming a stem cell or bone marrow donor for a loved one in need. If you are a blood relative, please proceed with completing ...

5. Cirugía - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation.

6. Neurología - Ensayos clínicos - Mayo Clinic

   ... benefits over other therapies. The data collected from this study will help facilitate research on proton beam radiation therapy and allow for collaborative ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

8. Metastatic castration-resistant prostate cancer (mCRPC)

   This is called metastatic castration-sensitive prostate cancer (mCSPC). If the cancer spreads and no longer responds to hormone therapy medicines, it's ...

9. Cirugía - Ensayos clínicos - Mayo Clinic

   Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... benefit and resistance to 131I-MIBG and crizotinib. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal ...